Table 4.
N | Inhibition % (4 μM) | IC50 (μM) | N | Inhibition % (4 μM) | IC50 (μM) | N | Inhibition % (4 μM) | IC50 (μM) |
---|---|---|---|---|---|---|---|---|
1 | 70 | 0.21 | 12 | 50 | 4 | 23 | 73 | 2.39 |
2 | 72 | 0.0047 | 13 | 65 | 1.99 | 24 | 36 | >4 |
3 | 72 | 0.15 | 14 | 83 | 0.01 | 25 | 44 | >4 |
4 | 54 | 3.8 | 15 | 69 | 2.08 | 26 | 73 | 2.48 |
5 | 44 | >4 | 16 | 68 | 2.20 | 27 | 76 | 1.93 |
6 | 35 | >4 | 17 | 67 | 2.60 | 28 | 62 | 2.00 |
7 | 50 | 4 | 18 | 72 | 2.69 | 29 | 49 | 4.28 |
8 | 83 | 0.26 | 19 | 71 | 2.62 | 30 | 46 | >4 |
9 | 56 | 0.001 | 20 | 55 | 1.51 | 31 | 46 | >4 |
10 | 63 | 0.001 | 21 | 50 | 4 | 32 | 46 | >4 |
11 | 40 | >4 | 22 | 72 | 2.76 | Nevirapine | 0.3 |